Who Paid My Doc
Rachel Raber
Plastic Surgery within the Head & Neck Dover, OH Physician Assistant
NPI 1124797840 CMS profile 10040287
515 Union Ave Ste 157, Dover, OH 44622
General payments
$638
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Rachel Raber of Dover, OH is reported in the CMS Open Payments database as having received $638 across 27 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 38th percentile of Plastic Surgery within the Head & Neck profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $61 | 3 | |
| 2023 | General | $291 | 9 | |
| 2022 | General | $238 | 12 | |
| 2021 | General | $48 | 3 |
Beside peers
- Rachel Raber
- Plastic Surgery within the Head & Neck median
- Middle half of Plastic Surgery within the Head & Neck
- National median
In program year 2025, general payments to Rachel Raber were reported at $61. Among 399 Plastic Surgery within the Head & Neck profiles paid that year, the median was $237 and the middle half received between $103 and $520.
Show as a table
| Year | Rachel Raber | Plastic Surgery within the Head & Neck median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $200 | $82–$550 | $163 |
| 2020 | $0 | $120 | $46–$330 | $114 |
| 2021 | $48 | $166 | $60–$382 | $132 |
| 2022 | $238 | $208 | $83–$530 | $149 |
| 2023 | $291 | $202 | $77–$538 | $160 |
| 2024 | $0 | $260 | $99–$645 | $164 |
| 2025 | $61 | $237 | $103–$520 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 10 drugsPart D claims
715
Drug cost
$3,173
Branded share of claims
11.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Methylprednisolone | Generic | 255 | $1,323 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 44 | $355 | |
| Diclofenac Sodium | Generic | 34 | $322 | |
| Prednisone | Generic | 114 | $306 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 37 | $234 | |
| Meloxicam | Generic | 78 | $225 | |
| Cephalexin | Generic | 11 | $137 | |
| Tramadol Hcl | Generic | 69 | $133 | |
| Tizanidine Hcl | Generic | 57 | $98 | |
| Gabapentin | Generic | 16 | $40 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 51 billing codesPaid by Medicare
$46,764
Medicare patients
331
Services billed
1,917
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Ischemic heart disease | 29% | |
| Diabetes | 24% | |
| Depression | 24% | |
| Chronic kidney disease | 22% | |
| Heart failure | 17% | |
| Atrial fibrillation | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose J7321 | Office | 42 | 137 | $7,391 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 35 | 242 | $173 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
27 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic Surgery within the Head & Neck in Ohio
Kate Clancy
Plastic Surgery within the Head & Neck · Lorain, OH
Timothy Morley
Plastic Surgery within the Head & Neck · Boardman, OH
Paul Dibiase
Plastic Surgery within the Head & Neck · Steubenville, OH
Reza Bolourian
Plastic Surgery within the Head & Neck · Powell, OH
Olivia Chapman
Plastic Surgery within the Head & Neck · Boardman, OH
Christopher Shumrick
Plastic Surgery within the Head & Neck · Cincinnati, OH
Related records
Plastic Surgery within the Head & Neck in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Plastic Surgery within the Head & Neck
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.